This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for IDEXX Laboratories's Median PS Value or its related term are showing as below:
IDXX'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.93 Med: 1.71 Max: 3.1
Current: 0.93
During the past 13 years, the highest Price to Median PS Value of IDEXX Laboratories was 3.10. The lowest was 0.93. And the median was 1.71.
IDXX's Price-to-Median-PS-Value is ranked worse than 58.02% of 81
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.88
vs IDXX: 0.93
IDEXX Laboratories Median PS Value Historical Data
The historical data trend for IDEXX Laboratories's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IDEXX Laboratories's Median PS Value
For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 9.7143.
IDEXX Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $45.158.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories (NAS:IDXX) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
IDEXX Laboratories's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
406.92
/
438.68
=
0.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEXX Laboratories Median PS Value Related Terms
Thank you for viewing the detailed overview of IDEXX Laboratories's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IDXX has been successfully added to your 